Oruka Therapeutics (ORKA) Other financing activities (2024)
Oruka Therapeutics' (ORKA) quarterly Other financing activities came in at -$174000.0 in Q4 2024, up 59.25% quarter-over-quarter from -$427000.0 in Q3 2024.
Oruka Therapeutics (ORKA) Other financing activities (2024) Analysis & Trends
Oruka Therapeutics' Other financing activities history runs 1 years deep, the most recent figure standing at -$174000.0 for Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oruka Therapeutics | 36.09 Mn | -795.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -174,000.00 |
| Dec 31, 2024 | -174,000.00 |
| Sep 30, 2024 | -427,000.00 |
| Sep 30, 2024 | -427,000.00 |